Vaccination

Report: Flu vaccine effective for 2022/2023 season

During the 2022 to 2023 influenza season, vaccination is effective for reducing the risk for medically attended influenza among children and adults aged younger than 65 years and for symptomatic influenza among children, ...

Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.

Diseases, Conditions, Syndromes

Rising cases of COVID-19 variant XBB.1.5

Flu cases and respiratory syncytial virus (RSV) rates are beginning to drop in the U.S.; however, reported cases of COVID-19 are increasing. A new COVID-19 omicron variant, XBB.1.5, is spreading quickly and being closely ...

page 5 from 34